(Q33358885)

26 July 2017

Phase II study of topotecan and paclitaxel for recurrent, persistent, or metastatic cervical carcinoma (English)

1 reference

26 July 2017

1 reference

Andrea B Troxel

6

0 references

Dawn L. Hershman

3

object named as

Dawn L Hershman

1 reference

26 July 2017

Amy D Tiersten

1

1 reference

26 July 2017

Meredith J Selleck

2

1 reference

26 July 2017

D Smith

4

1 reference

26 July 2017

Edward E Resnik

5

1 reference

26 July 2017

Lois B Brafman

7

1 reference

26 July 2017

Laureen Shriberg

8

1 reference

26 July 2017

language of work or name

English

0 references

publication date

1 February 2004

1 reference

26 July 2017

1 reference

26 July 2017

92

1 reference

26 July 2017

2

1 reference

26 July 2017

635-638

1 reference

26 July 2017

Cancer statistics, 2003.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.11.019

Cis-platinum in treatment of advanced or recurrent squamous cell carcinoma of the cervix: a phase II study of the Gynecologic Oncology Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.11.019

Randomized trial of three cisplatin dose schedules in squamous-cell carcinoma of the cervix: a Gynecologic Oncology Group study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.11.019

A randomized comparison of a rapid versus prolonged (24 hr) infusion of cisplatin in therapy of squamous cell carcinoma of the uterine cervix: a Gynecologic Oncology Group study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.11.019

Paclitaxel, an active agent in nonsquamous carcinomas of the uterine cervix: a Gynecologic Oncology Group Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.11.019

A Phase II study of topotecan in patients with squamous cell carcinoma of the cervix: a gynecologic oncology group study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.11.019

Synergistic interaction between topotecan and microtubule-interfering agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.11.019

Phase I trial and pharmacologic trial of sequences of paclitaxel and topotecan in previously treated ovarian epithelial malignancies: a Gynecologic Oncology Group study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.11.019

Phase II trial of paclitaxel and cisplatin in metastatic and recurrent carcinoma of the uterine cervix

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.11.019

Topotecan in squamous cell carcinoma of the cervix: A Phase II study of the Gynecologic Oncology Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.11.019

Paclitaxel has moderate activity in squamous cervix cancer. A Gynecologic Oncology Group study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.11.019

10.1016/J.YGYNO.2003.11.019

7 January 2021

Identifiers

DOI

1 reference

26 July 2017

1 reference